Sandoz’s Enbrel biosim case turned away at SCOTUS, giving Amgen’s blockbuster 8 more years of free rein

Sandoz’s Enbrel biosim case turned away at SCOTUS, giving Amgen’s blockbuster 8 more years of free rein
esagonowsky
Mon, 05/17/2021 – 15:33